VarCov Co’s Agios Pharmaceuticals AGIO Stock Holding History

VarCov Co’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-19,104	Closed	-$520K	–	370
2025 Q4	$520K	Buy	+19,104	New	+$670K	0.21%	170

Other funds holding AGIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

VarCov Co's AGIO Position: Q1 2026 in Review

VarCov Co sold out of Agios Pharmaceuticals (AGIO) in Q1 2026, closing a stake of 19,104 shares — an estimated $520K sold.

VarCov Co first reported a position in AGIO in Q4 2025 and held it in 1 quarter. The position peaked at $520K in Q4 2025. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

VarCov Co reported no remaining Agios Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
VarCov Co sold 19,104 Agios Pharmaceuticals shares in Q1 2026, an estimated $520K.
VarCov Co first reported a position in Agios Pharmaceuticals in Q4 2025 and held it in 1 quarter.
VarCov Co's Agios Pharmaceuticals position peaked at $520K in Q4 2025.
233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on VarCov Co's 13F filing for Q1 2026, filed 15 May 2026.